A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
To Evaluate the Efficacy and Safety of TQB3909 Tablets versus Investigator\'s Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Epistemonikos ID: 362c8cb7de924e90d001eb8132f1d1ac9ea0eefb
First added on: Aug 08, 2026